Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCC4 ABCA4 ABCB5 CFTR ABCB4 ABCC2	1.49e-06	49	146	6	GO:0140359
GeneOntologyMolecularFunction	ATPase-coupled inorganic anion transmembrane transporter activity	ABCC4 CFTR ABCC2	4.43e-05	10	146	3	GO:0043225
GeneOntologyMolecularFunction	glutathione peroxidase activity	GPX3 GPX5 GPX6 LTC4S	4.90e-05	28	146	4	GO:0004602
GeneOntologyMolecularFunction	alpha-L-fucosidase activity	FUCA1 FUCA2	5.31e-05	2	146	2	GO:0004560
GeneOntologyMolecularFunction	fucosidase activity	FUCA1 FUCA2	5.31e-05	2	146	2	GO:0015928
GeneOntologyMolecularFunction	xenobiotic transmembrane transporter activity	ABCC4 ABCB5 SLC43A3 ABCC2	1.07e-04	34	146	4	GO:0042910
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ABCC4 ABCA4 ABCB5 CFTR ABCB4 ABCC2	1.50e-04	109	146	6	GO:0042626
GeneOntologyMolecularFunction	adiponectin binding	ADIPOR1 ADIPOR2	1.59e-04	3	146	2	GO:0055100
GeneOntologyMolecularFunction	ABC-type xenobiotic transporter activity	ABCC4 ABCB5 ABCC2	1.63e-04	15	146	3	GO:0008559
GeneOntologyMolecularFunction	chloride channel regulator activity	CFTR CHRNA7 CHRFAM7A	1.63e-04	15	146	3	GO:0017081
GeneOntologyMolecularFunction	transporter activity	GABRD VMP1 ABCC4 ABCA4 RHBDF2 SLC38A9 SLC2A7 PIEZO1 ABCB5 CFTR MCL1 SLC43A3 ASIC5 TMC3 CHRNA7 ABCB4 TMEM120A PIEZO2 SLC25A13 ABCC2 CHRFAM7A XPR1	1.71e-04	1289	146	22	GO:0005215
GeneOntologyMolecularFunction	efflux transmembrane transporter activity	ABCC4 ABCB5 XPR1	2.00e-04	16	146	3	GO:0015562
GeneOntologyMolecularFunction	carbon-sulfur lyase activity	GSTM4 ACCS LTC4S	2.00e-04	16	146	3	GO:0016846
GeneOntologyMolecularFunction	mechanosensitive monoatomic ion channel activity	PIEZO1 TMC3 PIEZO2	2.88e-04	18	146	3	GO:0008381
GeneOntologyMolecularFunction	glutathione binding	GSTM1 GSTM4 LTC4S	2.88e-04	18	146	3	GO:0043295
GeneOntologyMolecularFunction	adipokinetic hormone receptor activity	ADIPOR1 ADIPOR2	3.16e-04	4	146	2	GO:0097003
GeneOntologyMolecularFunction	transmembrane transporter activity	GABRD ABCC4 ABCA4 SLC38A9 SLC2A7 PIEZO1 ABCB5 CFTR MCL1 SLC43A3 ASIC5 TMC3 CHRNA7 ABCB4 TMEM120A PIEZO2 SLC25A13 ABCC2 CHRFAM7A XPR1	3.80e-04	1180	146	20	GO:0022857
GeneOntologyMolecularFunction	oligopeptide binding	GSTM1 GSTM4 LTC4S	3.98e-04	20	146	3	GO:1900750
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCC4 ERCC3 ABCA4 VWA8 ABCB5 CFTR DDX55 ABCB4 MDN1 DDX60L ABCC2	4.08e-04	441	146	11	GO:0016887
GeneOntologyMolecularFunction	leukotriene-C4 synthase activity	GSTM4 LTC4S	5.23e-04	5	146	2	GO:0004464
GeneOntologyMolecularFunction	ATP-dependent activity	DNHD1 ABCC4 ERCC3 ABCA4 VWA8 ABCB5 CFTR DDX55 ABCB4 MDN1 DDX60L ABCC2 TOP2B	5.85e-04	614	146	13	GO:0140657
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR4K17 CCRL2 GPR55 OR2J1 EDNRA OR6N1 ADRA2B ADRB1 OR51M1 OR4A15 MRGPRX1 AGTR1 OR52E6 OR52E1 OR52E5 LTB4R	7.60e-04	884	146	16	GO:0004930
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	GABRD OR4K17 CCRL2 GPR55 OR2J1 CHRNA7 EDNRA OR6N1 LIFR ADRA2B ADRB1 OR51M1 OR4A15 MRGPRX1 AGTR1 OR52E6 OR52E1 OR52E5 LTB4R KIR2DS5 CHRFAM7A	8.50e-04	1353	146	21	GO:0004888
GeneOntologyMolecularFunction	neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential	GABRD CHRNA7 ADRB1 CHRFAM7A	9.73e-04	60	146	4	GO:0099529
GeneOntologyMolecularFunction	glutathione transferase activity	GSTM1 GSTM4 LTC4S	1.22e-03	29	146	3	GO:0004364
GeneOntologyMolecularFunction	peroxidase activity	GPX3 GPX5 GPX6 LTC4S	1.31e-03	65	146	4	GO:0004601
GeneOntologyMolecularFunction	ABC-type glutathione S-conjugate transporter activity	ABCC4 ABCC2	1.44e-03	8	146	2	GO:0015431
GeneOntologyMolecularFunction	alcohol transmembrane transporter activity	ABCC4 ABCA4	1.44e-03	8	146	2	GO:0015665
GeneOntologyMolecularFunction	oxidoreductase activity, acting on peroxide as acceptor	GPX3 GPX5 GPX6 LTC4S	1.47e-03	67	146	4	GO:0016684
GeneOntologyMolecularFunction	primary active transmembrane transporter activity	ABCC4 ABCA4 ABCB5 CFTR ABCB4 ABCC2	2.00e-03	178	146	6	GO:0015399
GeneOntologyMolecularFunction	postsynaptic neurotransmitter receptor activity	GABRD CHRNA7 ADRB1 CHRFAM7A	2.23e-03	75	146	4	GO:0098960
GeneOntologyMolecularFunction	adrenergic receptor activity	ADRA2B ADRB1	2.30e-03	10	146	2	GO:0004935
GeneOntologyMolecularFunction	serine-type endopeptidase activity	RHBDF1 RHBDF2 C1RL F12 IMMP1L PCSK9	2.77e-03	190	146	6	GO:0004252
GeneOntologyBiologicalProcess	positive regulation of CoA-transferase activity	CHRNA7 AGTR1 CHRFAM7A	2.66e-05	9	143	3	GO:1905920
GeneOntologyBiologicalProcess	organic hydroxy compound transport	ABCC4 ABCA4 CFTR LDLR CHRNA7 ABCB4 ADRA2B AGTR1 ABCC2 CHRFAM7A PCSK9	4.14e-05	358	143	11	GO:0015850
GeneOntologyBiologicalProcess	positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure	CHRNA7 CHRFAM7A	4.77e-05	2	143	2	GO:0001988
GeneOntologyBiologicalProcess	regulation of CoA-transferase activity	CHRNA7 AGTR1 CHRFAM7A	5.17e-05	11	143	3	GO:1905918
GeneOntologyBiologicalProcess	positive regulation of blood pressure	CHRNA7 ADRA2B ADRB1 AGTR1 CHRFAM7A	5.53e-05	59	143	5	GO:0045777
GeneOntologyBiologicalProcess	organic anion transport	EPRS1 ABCC4 SLC38A9 ARL6IP5 CFTR SLC43A3 SELENON ABCB4 NF1 SLC25A13 ABCC2 G6PC1 OC90	6.29e-05	515	143	13	GO:0015711
GeneOntologyBiologicalProcess	xenobiotic transport	ABCC4 ABCB5 SLC43A3 ABCB4 ABCC2	8.19e-05	64	143	5	GO:0042908
GeneOntologyBiologicalProcess	carboxylic acid transport	EPRS1 ABCC4 SLC38A9 ARL6IP5 SLC43A3 SELENON ABCB4 NF1 SLC25A13 ABCC2 OC90	1.38e-04	410	143	11	GO:0046942
GeneOntologyBiologicalProcess	baroreceptor response to decreased systemic arterial blood pressure	CHRNA7 CHRFAM7A	1.43e-04	3	143	2	GO:0001982
GeneOntologyBiologicalProcess	organic acid transport	EPRS1 ABCC4 SLC38A9 ARL6IP5 SLC43A3 SELENON ABCB4 NF1 SLC25A13 ABCC2 OC90	1.44e-04	412	143	11	GO:0015849
GeneOntologyBiologicalProcess	fucose metabolic process	FUCA1 FUCA2 FUT1	1.71e-04	16	143	3	GO:0006004
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	VMP1 APH1B HSD17B7 FMO3 RHBDF1 RHBDF2 PIEZO1 ARL6IP5 CFTR SGPP2 PTDSS2 SELENON PTGFRN FAF1 ATXN3L SCAP SERINC1 CNEP1R1 OR51M1 SEC62 LTC4S G6PC1 EIF2AK3 PIGO	2.27e-05	1327	149	24	GO:0042175
GeneOntologyCellularComponent	endoplasmic reticulum membrane	VMP1 APH1B HSD17B7 FMO3 RHBDF1 RHBDF2 PIEZO1 ARL6IP5 CFTR SGPP2 PTDSS2 SELENON PTGFRN FAF1 ATXN3L SCAP SERINC1 OR51M1 SEC62 LTC4S G6PC1 EIF2AK3 PIGO	4.43e-05	1293	149	23	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	VMP1 APH1B HSD17B7 FMO3 RHBDF1 RHBDF2 PIEZO1 ARL6IP5 CFTR SGPP2 PTDSS2 SELENON PTGFRN FAF1 ATXN3L SCAP SERINC1 OR51M1 SEC62 LTC4S G6PC1 EIF2AK3 PIGO	4.76e-05	1299	149	23	GO:0098827
GeneOntologyCellularComponent	PCSK9-LDLR complex	LDLR PCSK9	5.05e-05	2	149	2	GO:1990666
GeneOntologyCellularComponent	spine apparatus membrane	CHRNA7 CHRFAM7A	1.51e-04	3	149	2	GO:0098897
GeneOntologyCellularComponent	external side of apical plasma membrane	ABCC4 LCT	7.43e-04	6	149	2	GO:0098591
MousePheno	airway basal cell hyperplasia	CHRNA7 CHRFAM7A	6.02e-05	2	109	2	MP:0011115
MousePheno	abnormal airway basal cell differentiation	CHRNA7 CHRFAM7A	6.02e-05	2	109	2	MP:0011114
MousePheno	abnormal airway basal cell morphology	CHRNA7 CHRFAM7A	6.02e-05	2	109	2	MP:0011113
Domain	ABC_transporter_CS	ABCC4 ABCA4 ABCB5 CFTR ABCB4 ABCC2	7.58e-07	42	143	6	IPR017871
Domain	ABC_membrane	ABCC4 ABCB5 CFTR ABCB4 ABCC2	9.27e-07	24	143	5	PF00664
Domain	ABC_tran	ABCC4 ABCA4 ABCB5 CFTR ABCB4 ABCC2	1.71e-06	48	143	6	PF00005
Domain	ABC_TRANSPORTER_2	ABCC4 ABCA4 ABCB5 CFTR ABCB4 ABCC2	1.71e-06	48	143	6	PS50893
Domain	ABC_TRANSPORTER_1	ABCC4 ABCA4 ABCB5 CFTR ABCB4 ABCC2	1.93e-06	49	143	6	PS00211
Domain	ABC_TM1F	ABCC4 ABCB5 CFTR ABCB4 ABCC2	2.09e-06	28	143	5	PS50929
Domain	ABC1_TM_dom	ABCC4 ABCB5 CFTR ABCB4 ABCC2	2.09e-06	28	143	5	IPR011527
Domain	ABC_transporter-like	ABCC4 ABCA4 ABCB5 CFTR ABCB4 ABCC2	2.18e-06	50	143	6	IPR003439
Domain	GPX_AS	GPX3 GPX5 GPX6	1.50e-05	7	143	3	IPR029759
Domain	AAA	ABCC4 ABCA4 VWA8 ABCB5 CFTR ABCB4 MDN1 ABCC2	1.52e-05	144	143	8	SM00382
Domain	AAA+_ATPase	ABCC4 ABCA4 VWA8 ABCB5 CFTR ABCB4 MDN1 ABCC2	1.52e-05	144	143	8	IPR003593
Domain	GLUTATHIONE_PEROXID_2	GPX3 GPX5 GPX6	2.39e-05	8	143	3	PS00763
Domain	GLUTATHIONE_PEROXID_1	GPX3 GPX5 GPX6	2.39e-05	8	143	3	PS00460
Domain	Glutathione_peroxidase	GPX3 GPX5 GPX6	2.39e-05	8	143	3	IPR000889
Domain	GLUTATHIONE_PEROXID_3	GPX3 GPX5 GPX6	2.39e-05	8	143	3	PS51355
Domain	GPX_CS	GPX3 GPX5 GPX6	2.39e-05	8	143	3	IPR029760
Domain	GSHPx	GPX3 GPX5 GPX6	2.39e-05	8	143	3	PF00255
Domain	CFTR/ABCC7	ABCC4 CFTR	5.82e-05	2	143	2	IPR009147
Domain	PIEZO	PIEZO1 PIEZO2	5.82e-05	2	143	2	PF15917
Domain	FUC_metazoa-typ	FUCA1 FUCA2	5.82e-05	2	143	2	IPR016286
Domain	Piezo	PIEZO1 PIEZO2	5.82e-05	2	143	2	IPR027272
Domain	Fucosidase_C	FUCA1 FUCA2	5.82e-05	2	143	2	PF16757
Domain	Piezo_RRas_bdg	PIEZO1 PIEZO2	5.82e-05	2	143	2	PF12166
Domain	Glyco_hydro_29_CS	FUCA1 FUCA2	5.82e-05	2	143	2	IPR018526
Domain	Rhomboid_SP	RHBDF1 RHBDF2	5.82e-05	2	143	2	PF12595
Domain	Fucosidase_C	FUCA1 FUCA2	5.82e-05	2	143	2	IPR031919
Domain	Rhomboid_SP	RHBDF1 RHBDF2	5.82e-05	2	143	2	IPR022241
Domain	Piezo_RRas-bd_dom	PIEZO1 PIEZO2	5.82e-05	2	143	2	IPR031334
Domain	Alpha_L_fucos	FUCA1 FUCA2	5.82e-05	2	143	2	SM00812
Domain	Glyco_hydro_29	FUCA1 FUCA2	5.82e-05	2	143	2	IPR000933
Domain	Alpha_L_fucos	FUCA1 FUCA2	5.82e-05	2	143	2	PF01120
Domain	ALPHA_L_FUCOSIDASE	FUCA1 FUCA2	5.82e-05	2	143	2	PS00385
Domain	Piezo_dom	PIEZO1 PIEZO2	5.82e-05	2	143	2	IPR031805
Domain	DENND6	DENND6A DENND6B	5.82e-05	2	143	2	IPR024224
Domain	7tm_1	OR4K17 CCRL2 GPR55 OR2J1 EDNRA OR6N1 ADRA2B ADRB1 OR51M1 OR4A15 MRGPRX1 AGTR1 OR52E6 OR52E5 LTB4R	2.19e-04	677	143	15	PF00001
Domain	G_PROTEIN_RECEP_F1_1	OR4K17 CCRL2 GPR55 OR2J1 EDNRA OR6N1 ADRA2B ADRB1 OR51M1 OR4A15 MRGPRX1 AGTR1 OR52E6 OR52E5 LTB4R	2.48e-04	685	143	15	PS00237
Domain	G_PROTEIN_RECEP_F1_2	OR4K17 CCRL2 GPR55 OR2J1 EDNRA OR6N1 ADRA2B ADRB1 OR51M1 OR4A15 MRGPRX1 AGTR1 OR52E6 OR52E5 LTB4R	2.73e-04	691	143	15	PS50262
Domain	GPCR_Rhodpsn	OR4K17 CCRL2 GPR55 OR2J1 EDNRA OR6N1 ADRA2B ADRB1 OR51M1 OR4A15 MRGPRX1 AGTR1 OR52E6 OR52E5 LTB4R	2.77e-04	692	143	15	IPR000276
Domain	ABL9/DENND6_dom	DENND6A DENND6B	3.46e-04	4	143	2	IPR018307
Domain	Avl9	DENND6A DENND6B	3.46e-04	4	143	2	PF09794
Domain	Thioredoxin-like_fold	GPX3 GPX5 FAF1 GSTM1 GSTM4 GPX6	5.39e-04	132	143	6	IPR012336
Domain	WHEP_TRS_1	EPRS1 WARS1	5.73e-04	5	143	2	PS00762
Domain	WHEP-TRS	EPRS1 WARS1	5.73e-04	5	143	2	SM00991
Domain	WHEP-TRS	EPRS1 WARS1	5.73e-04	5	143	2	PF00458
Domain	WHEP-TRS_dom	EPRS1 WARS1	5.73e-04	5	143	2	IPR000738
Domain	GST_mu	GSTM1 GSTM4	5.73e-04	5	143	2	IPR003081
Domain	WHEP_TRS_2	EPRS1 WARS1	5.73e-04	5	143	2	PS51185
Domain	-	EPRS1 WARS1	8.56e-04	6	143	2	1.10.287.10
Domain	GST_C	EPRS1 GSTM1 GSTM4	1.00e-03	26	143	3	IPR004046
Domain	GST_C	EPRS1 GSTM1 GSTM4	1.00e-03	26	143	3	PF00043
Domain	S15_NS1_RNA-bd	EPRS1 WARS1	1.58e-03	8	143	2	IPR009068
Domain	Peptidase_S54_rhomboid	RHBDF1 RHBDF2	1.58e-03	8	143	2	IPR002610
Domain	-	DNHD1 RAN ABCC4 ERCC3 ABCA4 VWA8 ABCB5 CFTR HS3ST5 DDX55 ABCB4 MDN1 DDX60L ABCC2	1.78e-03	746	143	14	3.40.50.300
Domain	GPCR_Rhodpsn_7TM	OR4K17 CCRL2 GPR55 EDNRA OR6N1 ADRA2B ADRB1 OR51M1 OR4A15 MRGPRX1 AGTR1 OR52E6 LTB4R	1.94e-03	670	143	13	IPR017452
Domain	Peptidase_S54_rhomboid_dom	RHBDF1 RHBDF2	2.02e-03	9	143	2	IPR022764
Domain	Rhomboid	RHBDF1 RHBDF2	2.02e-03	9	143	2	PF01694
Domain	-	RHBDF1 RHBDF2	2.02e-03	9	143	2	1.20.1540.10
Domain	-	LCT FUCA1 FUCA2	2.40e-03	35	143	3	3.20.20.80
Domain	-	GPX3 GPX5 GSTM1 GSTM4 GPX6	2.48e-03	122	143	5	3.40.30.10
Domain	ADR_fam	ADRA2B ADRB1	2.52e-03	10	143	2	IPR002233
Domain	GST_C_3	GSTM1 GSTM4	2.52e-03	10	143	2	PF14497
Domain	Glyco_hydro_catalytic_dom	LCT FUCA1 FUCA2	3.05e-03	38	143	3	IPR013781
Domain	HlyIII	ADIPOR1 ADIPOR2	3.06e-03	11	143	2	PF03006
Domain	AdipoR/HlyIII-related	ADIPOR1 ADIPOR2	3.06e-03	11	143	2	IPR004254
Domain	Glutathione-S-Trfase_C-like	EPRS1 GSTM1 GSTM4	3.28e-03	39	143	3	IPR010987
Domain	-	EPRS1 GSTM1 GSTM4	3.28e-03	39	143	3	1.20.1050.10
Domain	VWFA	VWA8 MDN1 COL21A1 CPNE1	3.63e-03	82	143	4	PS50234
Domain	VWA	VWA8 MDN1 COL21A1 CPNE1	3.96e-03	84	143	4	SM00327
Domain	Neurotransmitter_ion_chnl_CS	GABRD CHRNA7 CHRFAM7A	4.93e-03	45	143	3	IPR018000
Domain	ATPase_dyneun-rel_AAA	VWA8 MDN1	4.99e-03	14	143	2	IPR011704
Domain	-	FUCA1 FUCA2	4.99e-03	14	143	2	2.60.40.1180
Domain	AAA_5	VWA8 MDN1	4.99e-03	14	143	2	PF07728
Domain	Neur_chan_memb	GABRD CHRNA7 CHRFAM7A	5.24e-03	46	143	3	PF02932
Domain	Neurotrans-gated_channel_TM	GABRD CHRNA7 CHRFAM7A	5.57e-03	47	143	3	IPR006029
Domain	-	GABRD CHRNA7 CHRFAM7A	5.57e-03	47	143	3	2.70.170.10
Domain	Neur_chan_LBD	GABRD CHRNA7 CHRFAM7A	5.57e-03	47	143	3	PF02931
Domain	NEUROTR_ION_CHANNEL	GABRD CHRNA7 CHRFAM7A	5.57e-03	47	143	3	PS00236
Domain	Neur_channel	GABRD CHRNA7 CHRFAM7A	5.57e-03	47	143	3	IPR006201
Domain	Neur_chan_lig-bd	GABRD CHRNA7 CHRFAM7A	5.57e-03	47	143	3	IPR006202
Domain	P-loop_NTPase	DNHD1 RAN ABCC4 ERCC3 ABCA4 VWA8 ABCB5 CFTR HS3ST5 DDX55 ABCB4 MDN1 DDX60L ABCC2	5.58e-03	848	143	14	IPR027417
Domain	Glyco_hydro_b	FUCA1 FUCA2	5.73e-03	15	143	2	IPR013780
Domain	VWF_A	VWA8 MDN1 COL21A1 CPNE1	7.07e-03	99	143	4	IPR002035
Domain	Peptidase_aspartic_dom	NAPSA RTL1	7.34e-03	17	143	2	IPR021109
Domain	SH2	SH2D4B BLK SUPT6H GRAP2	7.58e-03	101	143	4	PF00017
Pathway	KEGG_ABC_TRANSPORTERS	ABCC4 ABCA4 ABCB5 CFTR ABCB4 ABCC2	1.28e-06	44	113	6	M11911
Pathway	WP_CHOLESTASIS	ABCC4 LDLR ABCB4 ABCC2	1.38e-05	19	113	4	M45520
Pathway	KEGG_GLUTATHIONE_METABOLISM	GPX3 GPX5 GSTM1 GSTM4 GPX6	4.81e-05	50	113	5	M1840
Pathway	KEGG_MEDICUS_REFERENCE_GLUTATHIONE_BIOSYNTHESIS	GPX3 GPX5 GPX6	7.90e-05	11	113	3	M47926
Pathway	WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY	GPX3 GPX5 GSTM1 GSTM4 GPX6 ABCC2	9.45e-05	92	113	6	MM15823
Pathway	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	ABCC4 ABCA4 ABCB5 CFTR ABCB4 ABCC2	1.42e-04	99	113	6	MM14986
Pathway	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	ABCC4 ABCA4 ABCB5 CFTR ABCB4 ABCC2	1.77e-04	103	113	6	M758
Pubmed	Glutathione pathway genetic polymorphisms and lung cancer survival after platinum-based chemotherapy.	ABCC4 GPX3 GPX5 GSTM1 GSTM4 GPX6 ABCC2	4.73e-11	30	151	7	20200426
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	VMP1 ABCC4 WARS1 PIEZO1 C1RL PTDSS2 SLC43A3 DDX55 SELENON PTGFRN LDLR LIFR SCAP NF1 SEC62 FUCA2 ATM EIF2AK3 PIGO GALNT4 PCSK9	6.20e-08	1201	151	21	35696571
Pubmed	Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis.	LDLR CHRNA7 CHRFAM7A	8.02e-08	3	151	3	25345495
Pubmed	α7 Nicotinic acetylcholine receptor is expressed in human atherosclerosis and inhibits disease in mice--brief report.	LDLR CHRNA7 CHRFAM7A	8.02e-08	3	151	3	25324572
Pubmed	Reduced size and macrophage content of advanced atherosclerotic lesions in mice with bone marrow specific deficiency of alpha 7 nicotinic acetylcholine receptor.	LDLR CHRNA7 CHRFAM7A	8.02e-08	3	151	3	25826262
Pubmed	MRP4 and CFTR in the regulation of cAMP and β-adrenergic contraction in cardiac myocytes.	ABCC4 CFTR ADRB1	3.20e-07	4	151	3	22381067
Pubmed	Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies.	ABCC4 LDLR GSTM1 ADRB1 AGTR1 LTC4S ABCC2	4.89e-07	108	151	7	19956635
Pubmed	Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations.	HSD17B7 LDLR EDNRA ABCB4 ADIPOR1 SCAP AGTR1 G6PC1 ADIPOR2	1.61e-06	250	151	9	18660489
Pubmed	Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.	VMP1 ABCC4 PIEZO1 ARL6IP5 PTDSS2 SELENON SLC35F5 TMEM120A SERINC1 SLC25A13 SEC62 PIGO	2.06e-06	499	151	12	22810586
Pubmed	Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database.	ABCC4 ABCA4 ABCB5 ABCC2	2.35e-06	22	151	4	8894702
Pubmed	Association analysis of 33 lipoprotein candidate genes in multi-generational families of African ancestry.	LDLR ADIPOR2 PCSK9	2.77e-06	7	151	3	20308432
Pubmed	HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.	GPX3 GPX5 GPX6	2.77e-06	7	151	3	15910762
Pubmed	Human immunodeficiency virus type 1 Tat protein impairs selenoglutathione peroxidase expression and activity by a mechanism independent of cellular selenium uptake: consequences on cellular resistance to UV-A radiation.	GPX3 GPX5 GPX6	2.77e-06	7	151	3	11368344
Pubmed	A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response.	LDLR EDNRA ADRB1 AGTR1	4.02e-06	25	151	4	12544508
Pubmed	Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice.	GPX3 GPX5 GPX6	4.42e-06	8	151	3	10652368
Pubmed	Glutathione depletion associated with the HIV-1 TAT protein mediates the extracellular appearance of acidic fibroblast growth factor.	GPX3 GPX5 GPX6	6.61e-06	9	151	3	9501919
Pubmed	Adiponectin receptor-1 expression is decreased in the pancreas of obese mice.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	19062045
Pubmed	Genetic deletion of α7 nicotinic acetylcholine receptors induces an age-dependent Alzheimer's disease-like pathology.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	34453977
Pubmed	Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	23521765
Pubmed	Effect of α7 nicotinic acetylcholine receptor activation on cardiac fibroblasts: a mechanism underlying RV fibrosis associated with cigarette smoke exposure.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	28258105
Pubmed	The cholinergic anti-inflammatory system limits T cell infiltration into the neurodegenerative CNS, but cannot counteract complex CNS inflammation.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	19344760
Pubmed	PCSK9 acts as a chaperone for the LDL receptor in the endoplasmic reticulum.	LDLR PCSK9	1.87e-05	2	151	2	24144304
Pubmed	SERPING1 and F12 combined variants in a hereditary angioedema family.	F12 SERPING1	1.87e-05	2	151	2	29885370
Pubmed	Bidirectional Regulation of Aggression in Mice by Hippocampal Alpha-7 Nicotinic Acetylcholine Receptors.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	29114104
Pubmed	Antagonism of secreted PCSK9 increases low density lipoprotein receptor expression in HepG2 cells.	LDLR PCSK9	1.87e-05	2	151	2	19224862
Pubmed	Omental fat expression of adiponectin and adiponectin receptors in non-obese women with PCOS: a preliminary study.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	19909601
Pubmed	Characterization, regulation of the expression and putative roles of two glutathione peroxidase proteins found in the mouse epididymis.	GPX3 GPX5	1.87e-05	2	151	2	10645275
Pubmed	Reduced CHRNA7 expression in C3H mice is associated with increases in hippocampal parvalbumin and glutamate decarboxylase-67 (GAD67) as well as altered levels of GABA(A) receptor subunits.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	24836856
Pubmed	Serum proprotein convertase subtilisin/kexin type 9 and cell surface low-density lipoprotein receptor: evidence for a reciprocal regulation.	LDLR PCSK9	1.87e-05	2	151	2	23690465
Pubmed	Studies of sperm from mutant mice suggesting that two neurotransmitter receptors are important to the zona pellucida-initiated acrosome reaction.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	15948184
Pubmed	Alpha7 nicotinic acetylcholine receptor mediates chronic nicotine inhalation-induced cardiopulmonary dysfunction.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	35678315
Pubmed	Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.	LDLR PCSK9	1.87e-05	2	151	2	27470509
Pubmed	Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	12628457
Pubmed	Binding to the low-density lipoprotein receptor accelerates futile catalytic cycling in PCSK9 and raises the equilibrium level of intramolecular acylenzyme.	LDLR PCSK9	1.87e-05	2	151	2	19222187
Pubmed	Prenatal nicotine exposure alters lung function and airway geometry through α7 nicotinic receptors.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	22246862
Pubmed	Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion.	GSTM1 GSTM4	1.87e-05	2	151	2	3174634
Pubmed	Attenuation of Excess TNF-α Release in Crohn's Disease by Silencing of iRHOMs 1/2 and the Restoration of TGF-β Mediated Immunosuppression Through Modulation of TACE Trafficking.	RHBDF1 RHBDF2	1.87e-05	2	151	2	35585977
Pubmed	New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice.	LDLR PCSK9	1.87e-05	2	151	2	33737240
Pubmed	Involvement of AdipoR receptor in adiponectin-induced motility and alpha2beta1 integrin upregulation in human chondrosarcoma cells.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	19549705
Pubmed	Having excess levels of PCSK9 is not sufficient to induce complex formation between PCSK9 and the LDL receptor.	LDLR PCSK9	1.87e-05	2	151	2	24486405
Pubmed	Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	1400473
Pubmed	Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor.	LDLR PCSK9	1.87e-05	2	151	2	18753623
Pubmed	Differential expression of PIEZO1 and PIEZO2 mechanosensitive channels in ocular tissues implicates diverse functional roles.	PIEZO1 PIEZO2	1.87e-05	2	151	2	37820892
Pubmed	INT6/EIF3E interacts with ATM and is required for proper execution of the DNA damage response in human cells.	EIF3E ATM	1.87e-05	2	151	2	22508697
Pubmed	Activation of Alpha 7 Cholinergic Nicotinic Receptors Reduce Blood-Brain Barrier Permeability following Experimental Traumatic Brain Injury.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	26937017
Pubmed	PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells.	LDLR PCSK9	1.87e-05	2	151	2	25110901
Pubmed	Characterization of LDLR rs5925 and PCSK9 rs505151 genetic variants frequencies in healthy subjects from northern Chile: Influence on plasma lipid levels.	LDLR PCSK9	1.87e-05	2	151	2	31441123
Pubmed	Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	16650968
Pubmed	Long-term improvements in sensory inhibition with gestational choline supplementation linked to α7 nicotinic receptors through studies in Chrna7 null mutation mice.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	24462939
Pubmed	Probing the putative α7 nAChR/NMDAR complex in human and murine cortex and hippocampus: Different degrees of complex formation in healthy and Alzheimer brain tissue.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	29261717
Pubmed	Altered hippocampal circuit function in C3H alpha7 null mutant heterozygous mice.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	18199426
Pubmed	Neuronal nicotinic alpha7 receptors modulate inflammatory cytokine production in the skin following ultraviolet radiation.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	18077004
Pubmed	Smoking in adult attention-deficit/hyperactivity disorder: interaction between 15q13 nicotinic genes and Temperament Character Inventory scores.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	19462340
Pubmed	Dual action of adiponectin on insulin secretion in insulin-resistant mice.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	15358228
Pubmed	NMR structural analysis of alpha-bungarotoxin and its complex with the principal alpha-neurotoxin-binding sequence on the alpha 7 subunit of a neuronal nicotinic acetylcholine receptor.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	11790782
Pubmed	Regulation of adiponectin receptor gene expression in diabetic mice.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	15613685
Pubmed	Effect of a splice site mutation in LDLR gene and two variations in PCSK9 gene in Tunisian families with familial hypercholesterolaemia.	LDLR PCSK9	1.87e-05	2	151	2	21115573
Pubmed	Genetic deletion of α7 nAChRs reduces hippocampal granule and pyramidal cell number in both sexes but impairs pattern separation in males only.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	37746145
Pubmed	A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	19631623
Pubmed	Deletion of the alpha7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	15770102
Pubmed	LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers.	LDLR PCSK9	1.87e-05	2	151	2	26820623
Pubmed	Genes adapt to outsmart gene-targeting strategies in mutant mouse strains by skipping exons to reinitiate transcription and translation.	RHBDF1 RHBDF2	1.87e-05	2	151	2	32646486
Pubmed	Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation.	LDLR PCSK9	1.87e-05	2	151	2	17452316
Pubmed	Alpha 7 subunit of nAChR regulates migration of human mesenchymal stem cells.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	20720594
Pubmed	The regulation of adiponectin receptors in human prostate cancer cell lines.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	16899222
Pubmed	Blood lipid-related low-frequency variants in LDLR and PCSK9 are associated with onset age and risk of myocardial infarction in Japanese.	LDLR PCSK9	1.87e-05	2	151	2	29802317
Pubmed	Chrna7 genotype is linked with alpha7 nicotinic receptor expression but not alpha7 RNA levels.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	19368846
Pubmed	The role of dorsal root ganglia alpha-7 nicotinic acetylcholine receptor in complete Freund's adjuvant-induced chronic inflammatory pain.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	34514543
Pubmed	α7 nicotinic acetylcholine receptor (α7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	22183893
Pubmed	Evidence suggesting that the mouse sperm acrosome reaction initiated by the zona pellucida involves an alpha7 nicotinic acetylcholine receptor.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	12606407
Pubmed	Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	17716299
Pubmed	Low-abundant adiponectin receptors in visceral adipose tissue of humans and rats are further reduced in diabetic animals.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	20470935
Pubmed	Nicotine elicits prolonged calcium signaling along ventral hippocampal axons.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	24349346
Pubmed	Cholinergic modulation of appetite-related synapses in mouse lateral hypothalamic slice.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	16319313
Pubmed	Impaired synaptic plasticity in the visual cortex of mice lacking α7-nicotinic receptor subunit.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	25797465
Pubmed	Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	18310295
Pubmed	Pharmacologic activation of cholinergic alpha7 nicotinic receptors mitigates depressive-like behavior in a mouse model of chronic stress.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	29197398
Pubmed	Cholinergic signaling via the α7 nicotinic acetylcholine receptor regulates the migration of monocyte-derived macrophages during acute inflammation.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	38178134
Pubmed	In hippocampal oriens interneurons anti-Hebbian long-term potentiation requires cholinergic signaling via α7 nicotinic acetylcholine receptors.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	23325242
Pubmed	Identification of amino acid residues in the ligand binding repeats of LDL receptor important for PCSK9 binding.	LDLR PCSK9	1.87e-05	2	151	2	30617148
Pubmed	Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	21901321
Pubmed	Polymorphisms of ADIPOR1 and ADIPOR2 are associated with phenotypes of type 2 diabetes in Koreans.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	18466348
Pubmed	Adiponectin receptors are expressed in hypothalamus and colocalized with proopiomelanocortin and neuropeptide Y in rodent arcuate neurons.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	18971219
Pubmed	Neuronal nicotinic alpha7 receptors modulate early neutrophil infiltration to sites of skin inflammation.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	20624304
Pubmed	Non-hematopoietic deficiency of proprotein convertase subtilisin/kexin type 9 deficiency leads to more severe anemia in a murine model of sickle cell disease.	LDLR PCSK9	1.87e-05	2	151	2	33020528
Pubmed	Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells.	LDLR FUT1	1.87e-05	2	151	2	10330445
Pubmed	Mice homozygous for the L250T mutation in the alpha7 nicotinic acetylcholine receptor show increased neuronal apoptosis and die within 1 day of birth.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	10800961
Pubmed	The role of PIEZO ion channels in the musculoskeletal system.	PIEZO1 PIEZO2	1.87e-05	2	151	2	36717101
Pubmed	Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.	LDLR PCSK9	1.87e-05	2	151	2	33886544
Pubmed	Characterization of allelic variants at chromosome 15q14 in schizophrenia.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	16417613
Pubmed	Structural insights into adiponectin receptors suggest ceramidase activity.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	28329765
Pubmed	Localization of novel adiponectin receptor constructs.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	17118803
Pubmed	Regional variation in aortic AT1b receptor mRNA abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms.	LDLR AGTR1	1.87e-05	2	151	2	23119030
Pubmed	Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	11834293
Pubmed	in vitro Anti-Proliferative Effect of Adiponectin on Human Endometriotic Stromal Cells through AdipoR1 and AdipoR2 Gene Receptor Expression.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	26459399
Pubmed	Antagonism of Cerebral High Mobility Group Box 1 Ameliorates Dendritic Cell Dysfunction in Sepsis.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	34512319
Pubmed	Visual acuity is reduced in alpha 7 nicotinic receptor knockout mice.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	22281823
Pubmed	Central role of alpha7 nicotinic receptor in differentiation of the stratified squamous epithelium.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	12391028
Pubmed	Mouse muscle denervation increases expression of an alpha7 nicotinic receptor with unusual pharmacology.	CHRNA7 CHRFAM7A	1.87e-05	2	151	2	12562921
Pubmed	AdipoR1 and 2 are expressed on warm sensitive neurons of the hypothalamic preoptic area and contribute to central hyperthermic effects of adiponectin.	ADIPOR1 ADIPOR2	1.87e-05	2	151	2	22000082
Interaction	SLC22A4 interactions	VMP1 KNTC1 HSD17B7 PTDSS2 TMEM120A SERINC1 IMMP1L ATM SERPINF2 PIGO	1.32e-06	192	145	10	int:SLC22A4
GeneFamily	Adiponectin receptors\|Progestin and adipoQ receptor family	ADIPOR1 ADIPOR2	2.67e-05	2	94	2	293
GeneFamily	ATP binding cassette subfamily C	ABCC4 CFTR ABCC2	3.75e-05	13	94	3	807
GeneFamily	Selenoproteins	GPX3 SELENON GPX6	2.88e-04	25	94	3	890
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND4A DENND6A DENND6B	2.88e-04	25	94	3	504
GeneFamily	Adrenoceptors	ADRA2B ADRB1	9.40e-04	9	94	2	169
GeneFamily	Progestin and adipoQ receptor family	ADIPOR1 ADIPOR2	1.43e-03	11	94	2	930
GeneFamily	ATP binding cassette subfamily B	ABCB5 ABCB4	1.43e-03	11	94	2	806
GeneFamily	SH2 domain containing	SH2D4B BLK SUPT6H GRAP2	1.90e-03	101	94	4	741
GeneFamily	Olfactory receptors, family 52	OR52E6 OR52E1 OR52E5	2.11e-03	49	94	3	165
GeneFamily	Rhomboid family	RHBDF1 RHBDF2	2.34e-03	14	94	2	926
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	C1RL CSMD2 SUSD5	3.25e-03	57	94	3	1179
GeneFamily	Aminoacyl tRNA synthetases, Class I	EPRS1 WARS1	4.32e-03	19	94	2	131
GeneFamily	Glutathione S-transferases	GSTM1 GSTM4	7.42e-03	25	94	2	567
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000	NAPSA VMP1 APH1B CFTR PDLIM5 SGK2 AGTR1 SERPINF2 FGGY PIGO PCSK9	1.42e-06	267	138	11	gudmap_developingKidney_e14.5 whole kidney - wildtype_1000_k5
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_1000	NAPSA VMP1 APH1B EPRS1 HSD17B7 MIS18BP1 WARS1 CFTR SGPP2 PDLIM5 SGK2 GPX6 AGTR1 ATM SERPINF2 FGGY PIGO PCSK9	2.24e-06	761	138	18	gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_1000
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_500	NAPSA EPRS1 MIS18BP1 CFTR PDLIM5 SGK2 AGTR1 ATM SERPINF2 FGGY PIGO PCSK9	8.32e-06	385	138	12	gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_500
CoexpressionAtlas	kidney_adult_JuxtaGlom_Ren1_k-means-cluster#2_top-relative-expression-ranked_1000	NAPSA VWA8 SGPP2 GPX3 SGK2 GPX6 FUCA1 FUCA2 ABCC2 SERPINF2 G6PC1	1.17e-05	333	138	11	gudmap_kidney_adult_JuxtaGlom_Ren1_k2_1000
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_1000	NAPSA SGPP2 GPX3 ADRA2B GPX6 HERC3 FUCA2 ABCC2 FGGY	4.64e-05	256	138	9	gudmap_kidney_P0_JuxtaGlom_Ren1_k4_1000
CoexpressionAtlas	kidney_e10.5_UretericTip_HoxB7_k-means-cluster#1_top-relative-expression-ranked_1000	GPX3 GPX6 SLC25A13 ZC3H12C FUCA2 FGGY	9.19e-05	112	138	6	gudmap_kidney_e10.5_UretericTip_HoxB7_k1_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_1000	NAPSA APH1B SLC38A9 CFTR SGPP2 DNAAF9 SGK2 EML5 AGTR1 FUCA2 ABCC2 SERPINF2 G6PC1 FGGY PCSK9	1.26e-04	758	138	15	gudmap_developingKidney_e15.5_Proximal Tubules_1000
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C1RL F12 ABCB4 GSTM1 GSTM4 SERPING1 ABCC2 SERPINF2 G6PC1	6.01e-09	168	150	9	b98af4043dfa5dfa4413e482879fad88de484675
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C1RL F12 ABCB4 GSTM1 GSTM4 SERPING1 ABCC2 SERPINF2 G6PC1	6.01e-09	168	150	9	073b53d4cee6bc8c5c6fce51cf6cd9c316478f69
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FMO3 C1RL F12 ABCB4 GSTM4 SERPING1 ABCC2 SERPINF2 G6PC1	8.59e-09	175	150	9	5c38d4b6c03473d841e6203a7efaa6dcb2d59386
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F12 ABCB4 SGK2 GSTM1 GSTM4 SLC25A13 ABCC2 G6PC1	7.35e-08	160	150	8	c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSD17B7 F12 GSTM4 SERPING1 SERPINF2 G6PC1 ADIPOR2 PCSK9	9.33e-08	165	150	8	d449a568664a81d9b5538e8f409301448a32ac37
ToppCell	droplet-Liver-HEPATOCYTES\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F12 ABCB4 GSTM1 GSTM4 SERPING1 ABCC2 SERPINF2 G6PC1	1.12e-07	169	150	8	f195467438c589f87224bde7da720dea072d110c
ToppCell	droplet-Liver-HEPATOCYTES-1m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F12 ABCB4 GSTM1 GSTM4 SERPING1 ABCC2 SERPINF2 G6PC1	1.12e-07	169	150	8	7785cab967a33560830c394c918d6ce625103858
ToppCell	356C-Fibroblasts-Fibroblast-G\|356C / Donor, Lineage, Cell class and subclass (all cells)	FMO3 GPX3 EDNRA PIEZO2 COL21A1 ST6GALNAC5 AGTR1 SERPING1	1.60e-07	177	150	8	8220cc2fc0ee8764a67a3be51d75248be2453040
ToppCell	356C-Fibroblasts-Fibroblast-G-\|356C / Donor, Lineage, Cell class and subclass (all cells)	FMO3 GPX3 EDNRA PIEZO2 COL21A1 ST6GALNAC5 AGTR1 SERPING1	1.60e-07	177	150	8	7617270f49cd6b7ba66db72d20560cee985012b2
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCK5 C1RL LDLR F12 ABCB4 ABCC2 SERPINF2 PCSK9	1.98e-07	182	150	8	770ce9f3f4538d0181a0181543841bc964c68274
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCK5 C1RL LDLR F12 ABCB4 ABCC2 SERPINF2 PCSK9	1.98e-07	182	150	8	77ab860e2add49dad0c1ffbfc64278ad499dfbd5
ToppCell	facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCK5 C1RL LDLR F12 ABCB4 ABCC2 SERPINF2 PCSK9	1.98e-07	182	150	8	4921c7d5687cc79f896b39753bb621d7e3d2972f
ToppCell	facs-Liver-Hepatocytes-24m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCK5 C1RL LDLR F12 ABCB4 ABCC2 PCSK9	2.96e-06	183	150	7	d0721c6aa426953a520d40e976b6e65aa7ca65e8
ToppCell	COPD-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	ABCC4 GPX3 LDLR LIFR COL21A1 RASGEF1B ADIPOR2	3.92e-06	191	150	7	ef16ad1c1cd2c0c0377957398c98775b62a81754
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-2\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	GPX3 GPR55 EDNRA SCAP GPX6 SERPING1	4.20e-06	125	150	6	6cd741dd1c7ee6b16437cca7c15c99b5c95603fc
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PGM2L1 TMC3 F12 PDLIM5 EML5 CHRFAM7A XPR1	5.14e-06	199	150	7	b4824d3683a4e3025b8e74a0f1755b331b2a0ba7
ToppCell	background\|World / Sample and Cell Type and Tumor Cluster (all cells)	FMO3 GPX3 MCL1 F12 RASGEF1B SERPING1 G6PC1	5.14e-06	199	150	7	5a6d0e00bfe1351eea192b54020bedeef78854e9
ToppCell	background-Hepatocytes\|World / Sample and Cell Type and Tumor Cluster (all cells)	FMO3 GPX3 MCL1 F12 RASGEF1B SERPING1 G6PC1	5.31e-06	200	150	7	423cca10df6ae0489a8fe7e7df87e70364dac022
ToppCell	367C-Myeloid-Macrophage-SPP1+_Macrophage_2\|367C / Donor, Lineage, Cell class and subclass (all cells)	CCRL2 SLC43A3 ABCB4 ADRA2B RASGEF1B EIF2AK3	8.40e-06	141	150	6	e409da87da5a38ba4d0ccc5e3f8bd89f480f9dab
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_2\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	APH1B GSTM4 ST6GALNAC5 KIAA1755 ACCS PIGO	9.11e-06	143	150	6	abe6ec0f6956b87f394d537926eb2427fcfad93f
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SLC43A3 DNAAF9 THSD1 PIEZO2 ADRB1 CPNE1	1.55e-05	157	150	6	2c946c6ab284fac3c25db688ed0aabe5a3f9ffa5
ToppCell	facs-Kidney\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA GPX3 SGK2 ADRA2B SERPINF2 G6PC1	2.27e-05	168	150	6	d2f17a470e04f8f0edb111894027bcfc6ee1a12f
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	GPX3 SLC43A3 AGTR1 UGP2 SERPING1 FUCA1	2.35e-05	169	150	6	84b898a9fd8ced67c6a501d5cef6416f519902c4
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABCB5 CHRNA7 EDNRA ABCB4 COL21A1 CHRFAM7A	2.59e-05	172	150	6	458fe1ae92620882dbc95c989a6da9b2ca216b5b
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A GPX3 MCL1 LIFR DENND6A ADRB1	2.86e-05	175	150	6	1ea6cf9da26601646f57fa14d558a5e9e1f0b345
ToppCell	Control\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HS3ST5 THSD1 USP9Y LIFR ST6GALNAC5 LTC4S	3.05e-05	177	150	6	b8ff6940e31b749776e81ae4f5bbd577dba9749c
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR55 SELENON F12 GRAP2 G6PC1 CD96	3.15e-05	178	150	6	d9eba884e18a0c89bdc70c194bfe4d62cca164fa
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR55 SELENON F12 GRAP2 G6PC1 CD96	3.15e-05	178	150	6	b03aa1de9d20895ebad55f6fcd6fe7a49335db5a
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR55 SELENON F12 GRAP2 G6PC1 CD96	3.15e-05	178	150	6	0f5cf34609df791c8baebfdc6590f6eb4dbe0509
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CFTR SGPP2 PGM2L1 CSMD2 ST6GALNAC5 AGTR1	3.15e-05	178	150	6	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NAPSA ABCC4 CFTR SGPP2 LDLR EML5	3.79e-05	184	150	6	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FMO3 GPX3 C1RL CSMD2 SERPING1 CHRFAM7A	3.90e-05	185	150	6	9faa35ceb89ccd2979072286f063687c9f846ce3
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2\|TCGA-Kidney / Sample_Type by Project: Shred V9	GABRD FMO3 SLC43A3 THSD1 EDNRA COL21A1	4.02e-05	186	150	6	1e6526fc9e9381b7ace864588cc7bd80194338d6
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_3\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	NAPSA CCRL2 GPR55 GSTM4 SND1-IT1 FGGY	4.14e-05	187	150	6	689b3cc76f1e04bd35a7d3ce19e9f08744a7835b
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	NAPSA CCRL2 GPR55 GSTM4 SND1-IT1 FGGY	4.14e-05	187	150	6	4527d6426f2c4397e47f12439a13a8c14fd2aab2
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	NAPSA ABCC4 HSD17B7 WARS1 CFTR SGPP2	4.27e-05	188	150	6	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	3'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MARVELD1 SELENON ADRA2B DENND6A EIF2AK3 KRT10-AS1	4.40e-05	189	150	6	7dad62bd50c197838058e89abd0ee387de3e83cd
ToppCell	Fetal_29-31_weeks-Immune-B_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DENND4A MIS18BP1 RHBDF2 ABCB4 BLK EIF2AK3	4.53e-05	190	150	6	424550418c1bd4eb070cf3c41cf09fa9d89aef37
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM5 EDNRA PIEZO2 COL21A1 SUSD5 KIAA1755	4.53e-05	190	150	6	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HSD17B7 PGM2L1 DDX55 CPNE1 HERC3 SND1-IT1	4.53e-05	190	150	6	3f0c7d130f66faea778fe567604edf1b4cdf85b3
ToppCell	10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ARL6IP5 EIF3E BLK DENND6B CD96 TOP2B	4.80e-05	192	150	6	38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HSD17B7 PGM2L1 DDX55 CPNE1 HERC3 SND1-IT1	4.80e-05	192	150	6	c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A MCL1 LIFR ADRB1 SERPING1 LTC4S	4.94e-05	193	150	6	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A MCL1 LIFR ADRB1 SERPING1 LTC4S	4.94e-05	193	150	6	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPX3 SLC43A3 THSD1 EDNRA IMMP1L SERPING1	4.94e-05	193	150	6	7c0d84b92470bfda2db1e5007feee7c1235a0a78
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A MCL1 LIFR ADRB1 SERPING1 LTC4S	4.94e-05	193	150	6	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	10x5'-GI_small-bowel\|World / Manually curated celltypes from each tissue	TSPYL2 GPR55 LDLR LGALS4 GRAP2 CD96	4.94e-05	193	150	6	cd89dfe53a114078f06343049685883c8e26508f
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A MCL1 LIFR ADRB1 SERPING1 LTC4S	4.94e-05	193	150	6	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	Control-Myeloid-TRAM2\|Control / Condition, Lineage and Cell class	WARS1 ABCB5 CCRL2 SLC43A3 RASGEF1B SERPING1	5.08e-05	194	150	6	d951dd1274d3ff1ac30671ec4153a4a8bc97b53f
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	VMP1 WARS1 LDLR LIMK2 RASGEF1B SERPING1	5.23e-05	195	150	6	1992a1673b7213e25f3c76ac77da35c57daceddd
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_4\|COVID-19_Severe / Disease condition and Cell class	VMP1 WARS1 CCRL2 LDLR RASGEF1B SERPING1	5.23e-05	195	150	6	787ea9f38ad8e2a836222ca97f4d927f7e79517d
ToppCell	368C-Fibroblasts-Fibroblast-G\|368C / Donor, Lineage, Cell class and subclass (all cells)	FMO3 GPX3 EDNRA PIEZO2 COL21A1 SERPING1	5.53e-05	197	150	6	156155c2f0c1a2461e45803da578af18ee221660
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NAPSA ABCC4 CFTR TSPYL2 LDLR EML5	5.53e-05	197	150	6	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	normal_Lung-Fibroblasts-COL13A1+_matrix_FBs\|normal_Lung / Location, Cell class and cell subclass	FMO3 GPX3 EDNRA PIEZO2 COL21A1 AGTR1	5.53e-05	197	150	6	6c57ab2efb8363828e24211c4d45e58bb73a9a4d
ToppCell	Transverse-Dendritic_cell-Lymphoid_DC\|Dendritic_cell / Region, Cell class and subclass	DNHD1 USP9Y MTMR10 LGALS4 BLK PIEZO2	5.53e-05	197	150	6	8545baf923ddf84c5ce9414a36d810603be52401
ToppCell	PCW_10-12\|World / Celltypes from embryonic and fetal-stage human lung	DENND4A GPX3 USP9Y LIFR COL21A1 AGTR1	5.53e-05	197	150	6	47fd8b0d596c5db1a722473c8efbb17a6bbe7538
ToppCell	368C-Fibroblasts-Fibroblast-G-\|368C / Donor, Lineage, Cell class and subclass (all cells)	FMO3 GPX3 EDNRA PIEZO2 COL21A1 SERPING1	5.53e-05	197	150	6	d5d9263451f6c10cb3b9c17740183ca334e24851
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	NAPSA ABCC4 CFTR TSPYL2 SLC43A3 LDLR	5.53e-05	197	150	6	1a1bee8da6e04b65935c40373eaee4d6c046d9a1
ToppCell	tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	FMO3 ARL6IP5 EIF3E GPX3 PIEZO2 SERPING1	5.53e-05	197	150	6	44f37a98f07c3e46a7e8fd3b64c2b2b44d5bbe40
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NAPSA CFTR SGPP2 LDLR LGALS4 FGGY	5.53e-05	197	150	6	bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-G\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	FMO3 GPX3 EDNRA COL21A1 RASGEF1B SERPING1	5.53e-05	197	150	6	a21a710c824f9e5c7ef1674168d1ce5aef85bd35
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	WARS1 MCL1 LDLR RASGEF1B SERPING1 DDX60L	5.69e-05	198	150	6	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	wk_08-11-Mesenchymal-Fibroblast-intermediate_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	EIF3E LIFR PIEZO2 COL21A1 AGTR1 SERPING1	5.85e-05	199	150	6	f9e3fb974ba8fe1b6d99892577549ef143df9e08
ToppCell	(5)_Fibroblast-G\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	FMO3 GPX3 EDNRA PIEZO2 COL21A1 SERPING1	5.85e-05	199	150	6	b4a737575be9f8c65771832dd8cd25328d5dae0d
ToppCell	distal-Endothelial-Capillary-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SYN3 GPX3 THSD1 LIFR ADRB1 LTC4S	5.85e-05	199	150	6	d27fbd9a651821b2859dfa80bce4e6fc6f8299fc
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Pericyte\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FMO3 GPX3 EDNRA ADRA2B AGTR1 SERPING1	5.85e-05	199	150	6	bd9b36dcf61eaa628ce1b70d21c5783b64c29e8f
ToppCell	343B-Fibroblasts-Fibroblast-G\|343B / Donor, Lineage, Cell class and subclass (all cells)	FMO3 GPX3 EDNRA PIEZO2 COL21A1 SERPING1	5.85e-05	199	150	6	f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell	343B-Fibroblasts-Fibroblast-G-\|343B / Donor, Lineage, Cell class and subclass (all cells)	FMO3 GPX3 EDNRA PIEZO2 COL21A1 SERPING1	5.85e-05	199	150	6	9c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FMO3 GPX3 EDNRA ADRA2B AGTR1 SERPING1	5.85e-05	199	150	6	e751eb67510f8a5842dcfed44134160919cdb713
ToppCell	343B-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FMO3 GPX3 EDNRA COL21A1 RASGEF1B SERPING1	5.85e-05	199	150	6	212e89d097753790061310373a1fafba773488b6
ToppCell	343B-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FMO3 GPX3 EDNRA COL21A1 RASGEF1B SERPING1	5.85e-05	199	150	6	14b676aa289c0578a37be32cec3ea285c79d97cc
ToppCell	wk_20-22-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	GABRD LIFR PIEZO2 COL21A1 AGTR1 SERPING1	6.02e-05	200	150	6	0ed49c2177b58269ff7653db6be7d68633a5d34a
ToppCell	wk_08-11-Mesenchymal-Fibroblast\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	EIF3E EDNRA LIFR PIEZO2 COL21A1 SERPING1	6.02e-05	200	150	6	482dfbbd8958b64c31568dccbffe3cc9589f876b
ToppCell	COVID-19_Convalescent-PLT_3\|World / Disease Group and Platelet Clusters	VWA8 DNAAF9 SCAP ATM CD96	1.01e-04	137	150	5	bb54bb81b450462ad521b57e1a07a80ce1678e67
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITFG2 TSPYL2 CLYBL GRAP2 TOP2B	1.36e-04	146	150	5	159dd157a74f3c27dc1a1dcbbf0ed8f9462cac9e
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Chrm2_(Cerebellum_basket_cells_4)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	LCT GPX6 FUT1 SERPINF2	1.54e-04	80	150	4	54f520cca126810510479fbeade2e3f66fb5dd1b
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Chrm2_(Cerebellum_basket_cells_4)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	LCT GPX6 FUT1 SERPINF2	1.54e-04	80	150	4	ce38ea123853a1e1082a033fb779b63ea440661d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EDNRA PIEZO2 ADRA2B COL21A1 AGTR1	1.55e-04	150	150	5	8645b9c7f9511ed6cc9afe04440c2873a3094150
ToppCell	droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FMO3 F12 SLC25A13 SERPINF2 G6PC1	1.59e-04	151	150	5	cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4
ToppCell	droplet-Liver-Hepatocytes-24m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C1RL LGALS4 SERPING1 SERPINF2 G6PC1	1.64e-04	152	150	5	c21e2152b0130485659051d8fb7fb4589d1ec997
ToppCell	facs-Liver-Hepatocytes\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	C1RL F12 ABCB4 ABCC2 G6PC1	1.86e-04	156	150	5	e2cda3ad4e5f44a80133864c5a38b766afb952ce
ToppCell	367C-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ABCC4 FMO3 MARVELD1 ABCB5 SERPINF2	1.91e-04	157	150	5	f511871e1a004c6e9af08ee325ab1bfc41807487
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	F12 GSTM1 SERPING1 SERPINF2 G6PC1	1.97e-04	158	150	5	9f58428f70d1427b20122c5c1cc7bf521d0f4832
ToppCell	ICU-NoSEP-Lymphocyte-T_NK-Treg\|ICU-NoSEP / Disease, Lineage and Cell Type	SGPP2 GPX3 THSD1 USP9Y ABCC2	2.03e-04	159	150	5	d065ec02a4f3672ba53d4fea66029f1ce68f367f
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FMO3 CSMD2 LGALS4 DDX60L LTB4R	2.09e-04	160	150	5	636127753e3a22831f39d4c8170df40901e4329d
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FMO3 F12 SERPING1 SERPINF2 G6PC1	2.09e-04	160	150	5	8de1fc75241d9bf2b355afa0e9ef39fea1977177
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FMO3 CSMD2 LGALS4 DDX60L LTB4R	2.09e-04	160	150	5	cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63
ToppCell	NS-critical-d_16-33-Myeloid-Mast_cell\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ABCC4 SH2D4B GRAP2 LTC4S CHRFAM7A	2.09e-04	160	150	5	c61869d9dbba250270e59366e15af204e5b4395d
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FMO3 F12 SERPING1 SERPINF2 G6PC1	2.15e-04	161	150	5	274838cebdc7af1db32d309dfe42ef7ccd3c190b
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FMO3 F12 SERPING1 SERPINF2 G6PC1	2.27e-04	163	150	5	03d9fa615d9d02ef98e20f28a10aaa6894dd4960
ToppCell	droplet-Liver-Hepatocytes-18m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FMO3 F12 SERPING1 SERPINF2 G6PC1	2.27e-04	163	150	5	1c4de36cf8cdaabb981cda5c7ce7e5ae7b4280e3
ToppCell	droplet-Liver-Hepatocytes-18m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FMO3 F12 SERPING1 SERPINF2 G6PC1	2.27e-04	163	150	5	7e82c1b7849eca895732df2da74ac6430bd9ba7a
ToppCell	facs-Kidney-nan-24m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA GPX3 GSTM1 FUCA2 SERPINF2	2.41e-04	165	150	5	906321cb5f299d77436fb5540fd8c52d7532beca
ToppCell	facs-Kidney-nan-24m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA GPX3 GSTM1 FUCA2 SERPINF2	2.41e-04	165	150	5	02a09d0918b103aca21c36b42c5a8a8ebad8686c
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NAPSA CFTR LDLR CPNE1 HERC3	2.47e-04	166	150	5	575c325db88d6909cdf0d5e664bd9098b89d4401
ToppCell	facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPX3 F12 GSTM1 SERPING1 G6PC1	2.54e-04	167	150	5	3e3d8f6df2feefafad5b44ba0ebf5b5a0fe4ed58
ToppCell	facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPX3 F12 GSTM1 SERPING1 G6PC1	2.54e-04	167	150	5	3ad9f3122dbe96580f640388ef920ea209fc2349
ToppCell	facs-Heart-RA-24m-Lymphocytic\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA SGPP2 GPR55 BLK GRAP2	2.69e-04	169	150	5	dcf92121fb00e3b6498e2648363e90ac044ea396
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ABCB5 CHRNA7 KHDC3L CHRFAM7A PCSK9	2.69e-04	169	150	5	876e666220a4041826dac313082fdd44da15b2b1
ToppCell	droplet-Fat-Gat-18m-Lymphocytic-B_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NAPSA BLK ADRA2B RASGEF1B FUT1	2.76e-04	170	150	5	5185187ecf26b4c9eaa0c01ad52697ab8d075cc7
Drug	Glutathione	GPX3 GPX5 GSTM1 GSTM4 GPX6 LTC4S	1.18e-07	36	149	6	DB00143
Drug	hydroxyrubicin	ABCC4 ABCB5 LCT ABCC2 TOP2B	3.43e-07	23	149	5	CID000072398
Drug	epicholesterol	HSD17B7 ABCA4 RHBDF1 ABCB5 GPX5 LCT LDLR CHRNA7 ABCB4 ADRB1 SCAP AGTR1 FUT1 ABCC2 CHRFAM7A G6PC1 PCSK9	9.71e-07	636	149	17	CID000000304
Drug	arabinopyranose	SLC2A7 PGM2L1 ASIC5 LCT AGTR1 FUCA1 FUCA2 G6PC1 FGGY TOP2B XPR1	1.25e-06	261	149	11	CID000000229
Drug	pheophytin	ABCC4 ABCB5 LCT ABCB4 GSTM1 GSTM4 SLC25A13 UGP2 LTC4S ABCC2 G6PC1	2.82e-06	284	149	11	CID000000250
Drug	bupranolol	ABCB5 CFTR ABCB4 ADRA2B ADRB1 ACCS	3.55e-06	63	149	6	CID000002475
Drug	ethacrynic acid	ABCC4 ABCB5 GPX5 EDNRA GSTM1 GSTM4 LTC4S ABCC2	3.61e-06	138	149	8	CID000003278
Drug	8-azido-ADP	ABCA4 ABCB5 CFTR ABCB4	3.92e-06	17	149	4	CID000121934
Drug	benzbromarone	ABCC4 ABCB5 ABCB4 ABCC2 TOP2B	4.13e-06	37	149	5	CID000002333
Drug	verapamil	ABCC4 ABCA4 ABCB5 CFTR ASIC5 LDLR CHRNA7 EDNRA ABCB4 ADRA2B ADRB1 ABCC2 CHRFAM7A TOP2B	4.36e-06	490	149	14	CID000002520
Drug	3-isoreserpine	ABCC4 ABCA4 ABCB5 LDLR EDNRA ABCB4 ADRA2B ADRB1 ABCC2	4.64e-06	190	149	9	CID000005052
Drug	sulfobromophthalein	ABCC4 ABCB5 ABCB4 GSTM1 GSTM4 LTC4S ABCC2	5.23e-06	103	149	7	CID000005345
Drug	v 104	ABCB5 ABCB4 ABCC2	5.41e-06	6	149	3	CID000107262
Drug	Digocin	ABCB5 CFTR ABCB4 AGTR1 ABCC2 TOP2B	6.59e-06	70	149	6	CID000003062
Drug	guanethidine	FMO3 WARS1 CHRNA7 ADRA2B ADRB1 AGTR1 CHRFAM7A	9.66e-06	113	149	7	CID000003518
Drug	amiodarone	ABCB5 CFTR ASIC5 LDLR ABCB4 ADRB1 FUCA1 FUCA2	1.07e-05	160	149	8	CID000002156
Drug	niguldipine	ABCB5 ABCB4 ADRB1 TOP2B XPR1	1.11e-05	45	149	5	CID000001236
Drug	AC1LCF1F	ABCC4 ABCB5 ABCB4 GSTM1 CLYBL UGP2 CPNE1 ABCC2	1.12e-05	161	149	8	CID000627275
Drug	Bile Acids and Salts	ABCC4 CFTR MCL1 LDLR ABCB4 ABCC2	1.33e-05	79	149	6	ctd:D001647
Drug	aminotriazole	ABCB5 EIF3E GPX5 ABCB4 GSTM1 GSTM4 LTC4S CNOT1	1.47e-05	167	149	8	CID000001639
Drug	tBCEU	ABCB5 ABCB4 TOP2B	1.50e-05	8	149	3	CID000164059
Drug	nicotine glucuronide	ABCB5 ABCB4 ABCC2	1.50e-05	8	149	3	CID003035848
Drug	tXMP	ABCC4 ABCB5 ABCB4	1.50e-05	8	149	3	CID003081384
Drug	oxidized glutathione	ABCC4 ABCB5 CFTR GPX5 ABCB4 GSTM1 GSTM4 LTC4S ABCC2	1.94e-05	227	149	9	CID000000975
Drug	So324	ABCC4 ABCB5 ABCB4	2.24e-05	9	149	3	CID000462261
Drug	strychnine HCl	WARS1 ASIC5 CHRNA7 GSTM1 GSTM4 LTC4S CHRFAM7A TOP2B	2.62e-05	181	149	8	CID000005304
Drug	Atorvastatin Calcium	MCL1 LDLR EDNRA ABCB4 SGK2 ABCC2 G6PC1 EIF2AK3	3.19e-05	186	149	8	ctd:D000069059
Drug	AC1Q5QI1	EDNRA AGTR1 ABCC2	3.19e-05	10	149	3	CID000186002
Drug	AC1MZ4R5	ABCB5 ABCB4 TOP2B	3.19e-05	10	149	3	CID003842392
Drug	Texas Red	ABCC4 ABCB5 CFTR ABCC2	3.19e-05	28	149	4	CID000452705
Drug	oltipraz	ABCC4 MCL1 GSTM1 GSTM4 ABCC2	3.28e-05	56	149	5	ctd:C026209
Drug	vinblastine	ABCC4 ABCB5 CFTR CHRNA7 ABCB4 ABCC2 CHRFAM7A TOP2B	3.57e-05	189	149	8	CID000013342
Drug	SR-12813	ABCB5 LDLR LGALS4 SCAP	3.68e-05	29	149	4	CID000446313
Drug	fluvastatin	MCL1 LDLR SGK2 ABCC2 G6PC1 PCSK9	3.82e-05	95	149	6	ctd:C065180
Drug	AC1L9E0Q	ABCC4 ABCB5 ABCB4 ABCC2	4.23e-05	30	149	4	CID000443095
Drug	amphimedine	CFTR TOP2B	4.25e-05	2	149	2	CID000100819
Drug	oxoaporphine	CFTR TOP2B	4.25e-05	2	149	2	CID000326183
Drug	benzyl-beta-lactoside	CFTR LCT	4.25e-05	2	149	2	CID003462525
Drug	FL4c	FUCA1 FUCA2	4.25e-05	2	149	2	CID000124915
Drug	S)-cotinine	HSD17B7 FMO3 CHRNA7 GSTM1 ACCS CHRFAM7A	4.30e-05	97	149	6	CID000000408
Drug	norUDCA	ABCC4 LDLR ABCB4	4.36e-05	11	149	3	CID000192254
Drug	6-methylpurine-2'-deoxyriboside	ABCC4 ABCB5 ABCB4 ABCC2 TOP2B	4.97e-05	61	149	5	CID000097184
Drug	ivermectin	ABCB5 CFTR CHRNA7 ABCB4 ABCC2 CHRFAM7A	5.40e-05	101	149	6	CID006435110
Drug	AC1L8YYB	ABCC4 ABCB5 ABCC2 TOP2B	7.01e-05	34	149	4	CID000435167
Drug	AC1L85AO	ABCC4 ABCB5 ABCB4 ABCC2 TOP2B	7.27e-05	66	149	5	CID000372705
Drug	AC1L1AUV	ABCB5 ABCB4 TOP2B	7.49e-05	13	149	3	CID000051323
Drug	MDL 25,637	LCT FUCA1 FUCA2	7.49e-05	13	149	3	CID000128548
Drug	Dixan	PDLIM5 GSTM1 GSTM4 LTC4S	7.88e-05	35	149	4	CID000010404
Drug	octopamine	CFTR LGALS4 ADRA2B ADRB1 FUCA1 FUCA2	8.26e-05	109	149	6	CID000004581
Drug	aminals	FUCA1 FUCA2 G6PC1	9.48e-05	14	149	3	CID000075408
Drug	AD 288	ABCB5 ATM TOP2B	9.48e-05	14	149	3	CID000073553
Drug	robinetin	ABCB5 ABCB4 ABCC2	9.48e-05	14	149	3	CID005281692
Drug	tetramethylrosamine	ABCC4 ABCB5 ABCC2	9.48e-05	14	149	3	CID000443313
Drug	AC1L1TSE	ABCC4 ABCB5 ABCB4 LTB4R ABCC2	1.10e-04	72	149	5	CID000060719
Drug	PAK-104P	ABCC4 ABCB5 ABCC2	1.18e-04	15	149	3	CID000131368
Drug	AC1OAGYH	LCT FUCA1 FUCA2	1.18e-04	15	149	3	CID006857622
Drug	1, 3-diallylurea	ABCB5 ASIC5 BLK SERPINF2 TOP2B	1.26e-04	74	149	5	CID000074537
Drug	stilbene oxide	ABCB4 GSTM1 GSTM4 UGP2 LTC4S	1.26e-04	74	149	5	CID000028649
Drug	fluoroanilinoazatoxin	ABCB5 TOP2B	1.27e-04	3	149	2	CID000378896
Drug	NSC688503	ABCB5 TOP2B	1.27e-04	3	149	2	CID000390744
Drug	BIBW22BS	ABCB5 TOP2B	1.27e-04	3	149	2	CID000132088
Drug	AC1NSGRQ	ABCB5 CFTR	1.27e-04	3	149	2	CID005333904
Drug	neoeriocitrin	PDLIM5 SERPINF2	1.27e-04	3	149	2	CID000114627
Drug	S-(2,4-dinitrophenyl)glutathione	ABCC4 ABCC2	1.27e-04	3	149	2	ctd:C030190
Drug	methylazatoxin	ABCB5 TOP2B	1.27e-04	3	149	2	CID000148162
Drug	AC1MHUMP	LDLR LGALS4	1.27e-04	3	149	2	CID003011702
Drug	Wp159	ABCB5 TOP2B	1.27e-04	3	149	2	CID003060549
Drug	Ethoxyquin	ABCC4 GSTM1 GSTM4 ABCC2	1.34e-04	40	149	4	ctd:D005015
Drug	EUK-189	GPX3 GSTM1 GSTM4	1.44e-04	16	149	3	ctd:C436526
Drug	AC1L4BIC	ABCC4 ABCB5 ABCC2	1.44e-04	16	149	3	CID000153998
Drug	NSC 284682	ABCB5 ABCB4 TOP2B	1.44e-04	16	149	3	CID000072518
Drug	Gsts	RAN ABCC4 GPX5 GSTM1 GSTM4 LTC4S ABCC2	1.47e-04	173	149	7	CID000128079
Drug	AC1Q6O8B	ABCC4 LDLR ABCB4 ABCC2	1.48e-04	41	149	4	CID000000334
Drug	probenecid	ABCC4 ABCB5 ABCB4 CLYBL ABCC2 TOP2B	1.61e-04	123	149	6	CID000004911
Drug	AC1L1J6H	ABCB5 MCL1 LDLR ABCB4 SCAP ABCC2 ADIPOR2 PCSK9	1.68e-04	236	149	8	CID000004889
Drug	Pgh1	ABCB5 CFTR ABCB4	1.75e-04	17	149	3	CID005283048
Drug	BAY u9773	ABCC4 LTC4S LTB4R	1.75e-04	17	149	3	CID005071481
Drug	mannosylamine	GRAP2 FUCA1 FUCA2	1.75e-04	17	149	3	CID000192844
Drug	antibiotic G 418	CFTR ATM ABCC2	1.75e-04	17	149	3	ctd:C010680
Drug	AC1LAR6M	FUCA1 FUCA2 TOP2B	1.75e-04	17	149	3	CID000493588
Drug	NSC91998	ABCC4 ABCB5 ABCB4 ABCC2 TOP2B	1.93e-04	81	149	5	CID000005668
Drug	talinolol	ABCB5 ADRB1 ABCC2	2.09e-04	18	149	3	CID000068770
Drug	coproporphyrin I	PDLIM5 ABCB4 ABCC2	2.09e-04	18	149	3	CID000068271
Drug	hydroxylamine	FMO3 GPX5 ASIC5 GSTM1 GSTM4 SERINC1 LTC4S TOP2B	2.11e-04	244	149	8	CID000000787
Drug	4-epidoxorubicin	ABCC4 ERCC3 ABCB5 ARL6IP5 CFTR TSPYL2 GPX5 MCL1 ABCB4 GSTM1 GSTM4 LTC4S ATM ABCC2 TOP2B	2.12e-04	788	149	15	CID000001690
Drug	amsacrine	ABCC4 ABCB5 ABCC2 TOP2B	2.13e-04	45	149	4	CID000002179
Drug	Fructose	SLC2A7 LCT LDLR EDNRA AGTR1 G6PC1 EIF2AK3 ADIPOR2	2.23e-04	246	149	8	ctd:D005632
Drug	zinc chloride (ZnCl2	NAPSA CFTR F12 GSTM1 GSTM4 LTC4S PCSK9	2.29e-04	186	149	7	CID000005727
Drug	docetaxel	ABCC4 ABCA4 FMO3 MCL1 ABCB4 ABCC2	2.46e-04	133	149	6	ctd:C067311
Drug	Apa-sg	ABCC4 ABCB5 ABCC2	2.46e-04	19	149	3	CID000126348
Drug	P-113	EDNRA ADRA2B AGTR1 SERPING1	2.52e-04	47	149	4	CID000036736
Drug	lacto-N-hexaose	FUCA1 FUCA2	2.53e-04	4	149	2	CID000194173
Drug	AC1L3B2K	PDLIM5 SERPINF2	2.53e-04	4	149	2	CID000086193
Drug	BBR 2378	ABCB5 TOP2B	2.53e-04	4	149	2	CID000219053
Drug	D-arabinono-1,4-lactone	FUCA1 FUCA2	2.53e-04	4	149	2	CID000017723
Drug	9-methylphenazine-1-carboxylic acid	ABCB5 TOP2B	2.53e-04	4	149	2	CID004037810
Drug	1,3,4-trideoxynojirimycin	FUCA1 FUCA2	2.53e-04	4	149	2	CID000636936
Drug	ANA 2000	WARS1 LCT	2.53e-04	4	149	2	CID006336581
Drug	bromonitromethane	FUCA1 FUCA2	2.53e-04	4	149	2	CID000068423
Drug	NK-252	ABCB5 TOP2B	2.53e-04	4	149	2	CID000130889
Disease	cystic fibrosis (implicated_via_orthology)	ABCC4 ABCB5 CFTR ABCB4	6.73e-08	9	144	4	DOID:1485 (implicated_via_orthology)
Disease	macular degeneration (is_implicated_in)	ABCA4 GSTM1 ADIPOR1 SERPING1	8.75e-06	27	144	4	DOID:4448 (is_implicated_in)
Disease	cholestasis (implicated_via_orthology)	ABCB4 GSTM1 ABCC2	9.36e-06	9	144	3	DOID:13580 (implicated_via_orthology)
Disease	Hereditary angioneurotic edema	F12 SERPING1	2.37e-05	2	144	2	cv:C0019243
Disease	angioedema (is_implicated_in)	F12 SERPING1	2.37e-05	2	144	2	DOID:1558 (is_implicated_in)
Disease	hyperinsulinism (biomarker_via_orthology)	ADIPOR1 AGTR1 ADIPOR2	4.96e-05	15	144	3	DOID:2018 (biomarker_via_orthology)
Disease	Angioedemas, Hereditary	F12 SERPING1	7.07e-05	3	144	2	C0019243
Disease	cholestasis (biomarker_via_orthology)	ABCC4 CFTR ABCB4 ABCC2	9.72e-05	49	144	4	DOID:13580 (biomarker_via_orthology)
Disease	complement C1r subcomponent-like protein measurement	C1RL SERPING1	1.41e-04	4	144	2	EFO_0801495
Disease	hereditary angioedema (is_marker_for)	F12 SERPING1	1.41e-04	4	144	2	DOID:14735 (is_marker_for)
Disease	intrahepatic cholestasis (implicated_via_orthology)	ABCB4 SLC25A13	1.41e-04	4	144	2	DOID:1852 (implicated_via_orthology)
Disease	COVID-19 (is_implicated_in)	AGTR1 SERPING1 SERPINF2	1.42e-04	21	144	3	DOID:0080600 (is_implicated_in)
Disease	lung disease (is_implicated_in)	CFTR EDNRA GSTM1	1.64e-04	22	144	3	DOID:850 (is_implicated_in)
Disease	Fanconi Syndrome	GPX3 XPR1	2.34e-04	5	144	2	C0015624
Disease	Brugada syndrome (implicated_via_orthology)	GSTM1 GSTM4	2.34e-04	5	144	2	DOID:0050451 (implicated_via_orthology)
Disease	chronic obstructive pulmonary disease (is_implicated_in)	CFTR CHRNA7 GSTM1 ADRB1	2.59e-04	63	144	4	DOID:3083 (is_implicated_in)
Disease	fish consumption measurement	LIMK2 NF1 SLC25A13 CNOT1	2.75e-04	64	144	4	EFO_0010139
Disease	hypertension (is_implicated_in)	FMO3 EDNRA ADRA2B ADRB1 AGTR1	3.26e-04	121	144	5	DOID:10763 (is_implicated_in)
Disease	cognitive disorder (implicated_via_orthology)	CHRNA7 CHRFAM7A	3.50e-04	6	144	2	DOID:1561 (implicated_via_orthology)
Disease	rheumatoid arthritis (biomarker_via_orthology)	CHRNA7 CHRFAM7A	3.50e-04	6	144	2	DOID:7148 (biomarker_via_orthology)
Disease	glycocholenate sulfate measurement	ADCK5 ABCC2	3.50e-04	6	144	2	EFO_0800276
Disease	Non-alcoholic Fatty Liver Disease	LDLR ABCB4 GSTM1 ABCC2	3.88e-04	70	144	4	C0400966
Disease	Nonalcoholic Steatohepatitis	LDLR ABCB4 GSTM1 ABCC2	3.88e-04	70	144	4	C3241937
Disease	Colorectal Neoplasms	ABCC4 ABCA4 ABCB5 CFTR ABCB4 GSTM1 ABCC2	4.38e-04	277	144	7	C0009404
Disease	diastolic blood pressure, systolic blood pressure	GPX3 MCL1 F12 PDLIM5 EDNRA PIEZO2 CLYBL COL21A1 CNEP1R1 LTC4S FGGY	4.67e-04	670	144	11	EFO_0006335, EFO_0006336
Disease	lung cancer (is_implicated_in)	CFTR MCL1 CHRNA7 GSTM1	4.80e-04	74	144	4	DOID:1324 (is_implicated_in)
Disease	LDL cholesterol change measurement	LDLR PCSK9	4.89e-04	7	144	2	EFO_0007804
Disease	hereditary lymphedema (is_implicated_in)	PIEZO1 THSD1	4.89e-04	7	144	2	DOID:0050580 (is_implicated_in)
Disease	hereditary angioedema (is_implicated_in)	F12 SERPING1	4.89e-04	7	144	2	DOID:14735 (is_implicated_in)
Disease	complement C1r subcomponent measurement	C1RL SERPING1	4.89e-04	7	144	2	EFO_0008090
Disease	periodontitis (is_implicated_in)	GSTM1 ADRB1	4.89e-04	7	144	2	DOID:824 (is_implicated_in)
Disease	fatty liver disease (biomarker_via_orthology)	ABCC2 G6PC1 ADIPOR2	5.58e-04	33	144	3	DOID:9452 (biomarker_via_orthology)
Disease	lung non-small cell carcinoma (is_implicated_in)	ERCC3 MCL1 CHRNA7 ATM ABCC2	6.15e-04	139	144	5	DOID:3908 (is_implicated_in)
Disease	Cholestasis of pregnancy	ABCB4 ABCC2	6.50e-04	8	144	2	C0268318
Disease	Familial hypercholesterolemia	LDLR PCSK9	6.50e-04	8	144	2	cv:C0020445
Disease	Drug Allergy	GSTM1 LTC4S ABCC2	6.64e-04	35	144	3	C0013182
Disease	differentiated thyroid carcinoma	TRMO FAF1 PCNX2	6.64e-04	35	144	3	EFO_1002017
Disease	renovascular hypertension (implicated_via_orthology)	ADRB1 AGTR1	8.33e-04	9	144	2	DOID:1591 (implicated_via_orthology)
Disease	Degenerative Diseases, Central Nervous System	GPX3 GSTM1 GSTM4	9.15e-04	39	144	3	C0270715
Disease	thyroid carcinoma	TRMO PCNX2 CNEP1R1	9.15e-04	39	144	3	EFO_0002892
Disease	Neurodegenerative Disorders	GPX3 GSTM1 GSTM4	9.15e-04	39	144	3	C0524851
Disease	Degenerative Diseases, Spinal Cord	GPX3 GSTM1 GSTM4	9.15e-04	39	144	3	C0751733
Disease	aspirin use measurement	LDLR EDNRA PCSK9	9.15e-04	39	144	3	EFO_0007013
Disease	cholesterol in very small VLDL measurement	LDLR FUT1 PCSK9	9.85e-04	40	144	3	EFO_0022231
Disease	familial hypercholesterolemia (is_implicated_in)	LDLR PCSK9	1.04e-03	10	144	2	DOID:13810 (is_implicated_in)
Disease	adseverin measurement	C1RL CPNE1	1.04e-03	10	144	2	EFO_0801358
Disease	senile cataract (is_implicated_in)	GSTM1 ATM	1.26e-03	11	144	2	DOID:9669 (is_implicated_in)
Disease	obstructive sleep apnea (is_implicated_in)	EDNRA ADRB1	1.26e-03	11	144	2	DOID:0050848 (is_implicated_in)
Disease	esophagus squamous cell carcinoma (is_implicated_in)	GPX3 CHRNA7 GSTM1	1.39e-03	45	144	3	DOID:3748 (is_implicated_in)
Disease	nicotine dependence (implicated_via_orthology)	CHRNA7 CHRFAM7A	1.51e-03	12	144	2	DOID:0050742 (implicated_via_orthology)
Disease	papillary thyroid carcinoma	TRMO PCNX2	1.51e-03	12	144	2	EFO_0000641
Disease	aspartate aminotransferase measurement	MCMBP ABCA4 PIEZO1 MCL1 LCT ABCB4 GSTM1 BLK ADRB1 NF1 CPNE1 ABCC2	1.64e-03	904	144	12	EFO_0004736
Disease	total lipids in lipoprotein particles measurement	LDLR FUT1 PCSK9	1.68e-03	48	144	3	EFO_0022309
Disease	total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement	ADRB1 NF1 ZC3H12C	1.78e-03	49	144	3	EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612
Disease	apolipoprotein B to apolipoprotein A1 ratio	LDLR GSTM1 PCSK9	1.78e-03	49	144	3	EFO_0021897
Disease	esophageal cancer (is_implicated_in)	GPX3 GSTM1	1.78e-03	13	144	2	DOID:5041 (is_implicated_in)
Disease	atherosclerosis	LDLR EDNRA	1.78e-03	13	144	2	EFO_0003914
Disease	Sarcoma, Spindle Cell	MCL1 NF1	2.07e-03	14	144	2	C0205945
Disease	Sarcoma, Epithelioid	MCL1 NF1	2.07e-03	14	144	2	C0205944
Disease	response to statin, LDL cholesterol change measurement	LDLR PCSK9	2.38e-03	15	144	2	EFO_0007804, GO_0036273
Disease	Colorectal Carcinoma	ABCC4 ABCA4 ABCB5 CFTR ABCB4 GSTM1 LIFR NF1 ABCC2 PIGO	2.41e-03	702	144	10	C0009402
Disease	Antithrombotic agent use measurement	LDLR EDNRA PCSK9	2.48e-03	55	144	3	EFO_0009925
Disease	leukemia	GSTM1 NF1 ATM	2.48e-03	55	144	3	C0023418
Disease	free cholesterol to total lipids in large HDL percentage	LDLR GSTM1 PCSK9	2.61e-03	56	144	3	EFO_0022279
Disease	level of Sterol ester (27:1/18:1) in blood serum	LDLR PCSK9	2.71e-03	16	144	2	OBA_2045195
Disease	irritable bowel syndrome symptom measurement	CHRNA7 DDX60L CHRFAM7A	2.89e-03	58	144	3	EFO_0021536
Disease	low density lipoprotein particle size measurement	LDLR GSTM1 PCSK9	2.89e-03	58	144	3	EFO_0008593
Disease	level of Sphingomyelin (d34:1) in blood serum	LDLR PCSK9	3.44e-03	18	144	2	OBA_2045175
Disease	non-alcoholic fatty liver disease (is_implicated_in)	ABCC2 ADIPOR2	3.44e-03	18	144	2	DOID:0080208 (is_implicated_in)
Disease	Hypercholesterolemia, Familial	LDLR PCSK9	3.44e-03	18	144	2	C0020445
Disease	anorectal malformation	CSMD2 SUSD5	3.83e-03	19	144	2	MONDO_0019938
Disease	Alopecia	EDNRA ABCC2	3.83e-03	19	144	2	C0002170
Disease	type 2 diabetes mellitus (is_marker_for)	GPX3 F12 FUCA1 G6PC1	4.51e-03	136	144	4	DOID:9352 (is_marker_for)
Disease	Benign Neoplasm	GPX3 GPR55 ATM	4.52e-03	68	144	3	C0086692
Disease	Neoplasms	GPX3 GPR55 ATM	4.52e-03	68	144	3	C0027651
Disease	hyperglycemia (biomarker_via_orthology)	ADIPOR1 ADRB1	4.67e-03	21	144	2	DOID:4195 (biomarker_via_orthology)
Disease	Sarcoma	MCL1 NF1	4.67e-03	21	144	2	C1261473
Disease	esophagus adenocarcinoma (is_implicated_in)	GPX3 GSTM1	4.67e-03	21	144	2	DOID:4914 (is_implicated_in)
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	LDLR PCSK9	4.67e-03	21	144	2	EFO_0022246

Protein segments in the cluster

Peptide	Gene	Start	Entry
CWLPFFLANVVKAFH	ADRB1	336	P08588
IILLHVFWGIVFFDG	APH1B	166	Q8WW43
GKIWPLFPVFHQFLE	DCUN1D4	226	Q92564
TPFLPADETFWKHFL	CCRL2	186	O00421
FDEGLALAHFVWIAP	CFTR	191	P13569
WKIALPVGFGAHIQF	CSMD2	1996	Q7Z408
KWNFSVGHFELRYIP	EIF2AK3	256	Q9NZJ5
SANPFHWDLIGKNLF	ABCA4	1866	P78363
HFQGFWRNKFDPSLT	SERPINF2	236	P08697
KEPGWFRFVFSDQVH	ACCS	451	Q96QU6
KQFFHSVLAQDIGWF	ABCB5	141	Q2M3G0
FSWIPHQIFTFLDVL	AGTR1	251	P30556
VHDIRWNFEKFLVGP	GPX3	176	P22352
CKVPHGLFQFFFWIG	ADRA2B	401	P18089
INVFKLLAGRWPFDH	EDNRA	136	P25101
WPFDHNDFGVFLCKL	EDNRA	146	P25101
HPSFGFSWVLQDLKG	ADCK5	256	Q3MIX3
SFLFALIWGFGAHLP	DNHD1	2286	Q96M86
LGVTNPFFIKTLQHW	DENND6B	331	Q8NEG7
WFPFDVQHCKLKFGS	CHRNA7	156	P36544
PEEIQWFADKFSFHL	CLYBL	141	Q8N0X4
LSHWPFFDAFRKFLT	DENND4A	316	Q7Z401
VFHTNRGPIKFNVWD	RAN	51	P62826
FFPGKCDIWFHSHQL	ADIPOR2	336	Q86V24
IFFKIWPLSDFGFLR	IMMP1L	141	Q96LU5
AFHFNPRFDGWDKVV	LGALS4	61	P56470
FFFNPLHLCSWIKDE	CFAP99	121	D6REC4
SMHLWVGFPFFAVFL	OR52E1	21	Q8NGJ3
WSQVAEFIILGFPHL	OR6N1	6	Q8NGY5
DFFLLLGFSNWPHLE	OR2J1	11	Q9GZK6
LGFSNWPHLEVVLFV	OR2J1	16	Q9GZK6
FPGKFDIWFQSHQIF	ADIPOR1	326	Q96A54
LSFHWKPGQFVFKGD	KIAA0100	1171	Q14667
EFTGIDNLWGIHPFF	MDN1	1696	Q9NU22
VVGRLQKPCFFFHWL	FMO3	501	P31513
FGFPENWKEHIDNFL	MIS18BP1	461	Q6P0N0
DGAVHWLTNFIIGFL	SLC2A7	421	Q6PXP3
FREWFSKPANLHGVI	MTMR10	631	Q9NXD2
FGLNVKLFWEKFVPT	LIMK2	556	P53671
TEWVHFFQKLDPFLA	KIAA1755	716	Q5JYT7
TVKLFWETFHEFPLE	HERC3	961	Q15034
KSWALFHLEEPNIAF	KIAA1109	4676	Q2LD37
TKHFPEFSQILWIGG	DDX55	106	Q8NHQ9
LGVKSFKWGQNLHFF	DDX60L	51	Q5H9U9
FGKHWFNLNSLLAGP	ATXN3L	126	Q9H3M9
WLKYFPIEQFHVVDG	HS3ST5	241	Q8IZT8
WGSSFHVFAQLFAIP	PCNX2	1301	A6NKB5
IHFSAKDVINEAWFP	PCSK9	416	Q8NBP7
PLFLATLWVAGIFFH	LTC4S	61	Q16873
AWIGGFLHSLVQFLF	OR4A15	176	Q8NGL6
LTSFPGLEGIKHWIF	OR51M1	26	Q9H341
GLEGIKHWIFIPFFF	OR51M1	31	Q9H341
GLEDVHIWIGFPFFS	OR52E6	21	Q96RD3
YIWPFGNHSVDKFLA	OR4K17	261	Q8NGC6
EGFHFEETLPGFKWI	PGM2L1	401	Q6PCE3
AKFGVFIHWGVFSVP	FUCA1	56	P04066
HYKVFLSWAQLLPAG	LCT	86	P09848
LPFHLIFFGTAQNFW	KNTC1	1591	P50748
LPDTFIVNAKSAWFH	GABRD	121	O14764
GLAQGIFVFIAHFWS	ABCC2	1031	Q92887
FLVALGKSWHPEEFN	PDLIM5	431	Q96HC4
PHFTWLQAVFTNFPV	OC90	61	Q02509
RLPNGHVNFEKFWEL	RASGEF1B	391	Q0VAM2
TWSAKVFFPLEVFGF	GPR55	176	Q9Y2T6
WFPFDVQHCKLKFGS	CHRFAM7A	66	Q494W8
AEGWFHLFDLTPAKV	ITFG2	86	Q969R8
APFFLHFLAQGTWSF	LTB4R	71	Q15722
VAFFLLQGAWPHEGF	KIR2DS5	11	Q14953
QKFFHAILRQEIGWF	ABCB4	151	P21439
DQVTVFLHFLWAGPL	ABCC4	206	O15439
LPAWFDQAKFGIFIH	FUCA2	46	Q9BTY2
DQAKFGIFIHWGVFS	FUCA2	51	Q9BTY2
GQFLTVIGAFWHLTK	ATM	1016	Q13315
FFFILHFWVTILPAK	DEFB110	6	Q30KQ9
GHFFDLPDFLSWKAT	FGGY	166	Q96C11
LFPIWFHLQEAVGIK	G6PC1	46	P35575
PANIIWHFKEDGTIF	GALNT4	526	Q8N4A0
WTAPEAIHFGVFTIK	BLK	401	P51451
AKLGNFPWQAFTSIH	C1RL	251	Q9NZP8
FANPQVKTLFDEGWH	COL21A1	336	Q96P44
KLPELDWFLQHFAIS	DNAAF9	701	Q5TEA3
LGVTNPFFAKTLQHW	DENND6A	351	Q8IWF6
AVAKFGVIFFLWHIV	ASIC5	121	Q9NY37
HWSLFVFFNHPKGRD	EIF3E	216	P60228
PYNGTEALVWLFHQK	HSD17B7	261	P56937
PFLFVLWDQQHKFPV	SERPING1	476	P05155
GPVHFALFVSVLFWL	MARVELD1	56	Q9BSK0
FSWFHSEFLKNPKVV	KHDC3L	31	Q587J8
IGGADHSVFQWKFIP	EML5	581	Q05BV3
LWVAPDGHIFLEAFS	ERCC3	76	P19447
LQIVFDFVASKGFPW	FAF1	596	Q9UNN5
LHEGLSKPVYVINWF	FAM104B	81	Q5XKR9
VHDIRWNFEKFLVGP	GPX5	176	O75715
VHDIRWNFEKFLVGP	GPX6	176	P59796
IDIQFPKWFHEGLSR	GRAP2	51	O75791
SVFPWHKNLLAVDVF	SCAP	101	Q12770
LGFHLEFHWFIPTEF	SLC38A9	336	Q8NBW4
FLEFFRQGDGKWHLV	CPNE1	161	Q99829
LSWHLPGNFAKINFL	LIFR	451	P42702
LVKQRGWDGFVEFFH	MCL1	306	Q07820
DWLSHPLGIVQGFFA	MCMBP	6	Q9BTE3
GLEDVHVWIGFPFFA	OR52E5	21	Q8NH55
SLLFWKVHHLFLEGF	SND1-IT1	56	Q9HBX3
FEPQLLRFFHKNEIW	F12	136	P00748
FLKLSGFPCSWTFFH	FUT1	161	P19526
WFAVHSFGLDKAPVL	PTGFRN	731	Q9P2B2
RLTVLLPGHWVFFFS	RTL1	961	A6NKG5
VGHLIPFIFTKWLQD	WARS1	171	P23381
WVFSQLIKIFHSLGP	SYN3	206	O14994
EKLLPHIWGNVGFVF	RPLP0P6	76	Q8NHW5
KHLFWFPAEAFHKPG	SUSD5	291	O60279
HVKRWFGFLEAQQAF	EPRS1	146	P07814
EKDFPVWFGSVVGHI	TMC3	666	Q7Z5M5
QKVQFSWLFFAGAIP	SLC35F5	446	Q8WV83
IKNHVFFSPINWDDL	SGK2	286	Q9HBY8
NWPSLLKHGFLEEFI	TOP2B	581	Q02880
LPFLFFGHFWQLFNA	TMEM120A	276	Q9BXJ8
IAFPGKHFQEISWFL	RPL7L1	201	Q6DKI1
KHFQEISWFLCPFHL	RPL7L1	206	Q6DKI1
QHFSQFLGKRPWFVG	GSTM4	136	Q03013
PWFVGDKITFVDFLA	GSTM4	146	Q03013
VFTGFVWAAHNKDVL	ARL6IP5	76	O75915
PWFAGNKITFVDFLV	GSTM1	146	P09488
FHNIWDKLDGFVPAH	PTDSS2	186	Q9BVG9
FGLLPWIDNFAHISG	RHBDF1	761	Q96CC6
VLFGWPSLVFVFKNE	SLC43A3	26	Q8NBI5
FNIHFFQPDWKPESL	ST6GALNAC5	311	Q9BVH7
LEHFRLFFVTKVQWP	IQANK1	526	A8MXQ7
PFGIQFFLFLWIHVD	MRGPRX1	231	Q96LB2
QKVSFFTSLWNHPFF	CNEP1R1	56	Q8N9A8
DPRAAVHNGFWFFKF	SERINC1	116	Q9NRX5
GVTIGFWINHFFQLV	SGPP2	286	Q8IWX5
FWINHFFQLVSKPAE	SGPP2	291	Q8IWX5
PFNWDSEFVQLHFGK	SLC25A13	126	Q9UJS0
FIELIKNPAFKFWNH	CNOT1	2326	A5YKK6
FPTVNGLFRWFKDHY	SUPT6H	1501	Q7KZ85
VFTAPFHKVGFADFW	XPR1	381	Q9UBH6
LFHRFLQEKGPSVDW	UGP2	61	Q16851
GLEQFSHVWILFVFH	TRMO	76	Q9BU70
DLIIQHIPGFWVKAF	TSPYL2	256	Q9H2G4
FPKANITWFIDGSFL	CD96	296	P40200
HFWFLPNLTADVGFI	SEC62	261	Q99442
AFLKVEWPVFHVDLN	THSD1	121	Q9NS62
FWFSPAQFTGHIILS	SELENON	306	Q9NZV5
FIIIVFGFWAFGKHS	PIEZO2	2201	Q9H5I5
TDFLSKWFVVFPGFA	NF1	1656	P21359
LPQVFLKPWIFVEHF	KRT10-AS1	51	Q8N816
KLAWDFSPGQLDHLF	USP9Y	456	O00507
VFPAIHWHAAFVGFP	PIGO	911	Q8TEQ8
ERNTKFIAPWFHGII	SH2D4B	316	Q5SQS7
LFQFGFFPWNSHVVL	PIEZO1	1746	Q92508
DFIIIIFGFWAFGKH	PIEZO1	1971	Q92508
WFLERGHKDITVFVP	ZC3H12C	276	Q9C0D7
FHGTPVTIENFLNWK	RWDD1	141	Q9H446
AHQWLGPEFLTMFFF	VWA8	591	A3KMH1
TFHALFNQPLTPVFW	TRIM65	476	Q6PJ69
PWIDNIAHIFGFLSG	RHBDF2	766	Q6PJF5
EFGVGVNIFWKHLPS	TYW5	241	A2RUC4
LHFLKQDIPALSWEF	UNC79	1151	Q9P2D8
ITCGHFLVPFWTFFG	VMP1	276	Q96GC9
AHPFSLAVFEDKVFW	LDLR	606	P01130
LWEPSLVFAFAHFDG	NAPSA	171	O96009